Related Experiment Video
Updated: Jul 10, 2026
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
A personalized mRNA signature for predicting hypertrophic cardiomyopathy applying machine learning methods
Jue Gu1, Yamin Zhao2, Yue Ben1
1Affiliated Hospital of Nantong University, No.20 Xisi Road, Nantong, 226000, Jiangsu Province, China.
Insights
Researchers developed a new hypertrophic cardiomyopathy (HCM) signature using bioinformatics and machine learning. This signature identifies key genes impacting cardiac function, aiding early diagnosis and treatment of HCM.
Area of Science:
- Cardiovascular Research
- Bioinformatics
- Genomics
Background:
- Hypertrophic cardiomyopathy (HCM) is a significant cause of cardiac dysfunction and sudden cardiac death.
- Identifying reliable biomarkers for HCM is crucial for timely diagnosis and intervention.
Purpose of the Study:
- To develop a predictive signature for hypertrophic cardiomyopathy (HCM) using bioinformatics and machine learning.
- To identify key genes and pathways involved in HCM pathogenesis.
- To validate the clinical significance of identified genes in a model organism.
Main Methods:
- Differential gene expression analysis of HCM and normal tissue data from public databases.
- Gene Ontology (GO) and KEGG pathway enrichment analysis.
- Weighted Gene Co-expression Network Analysis (WGCNA) and machine learning algorithms (SVM-RFE, LASSO) for hub gene identification.
- Zebrafish model to assess the functional impact of identified hub genes on cardiac development.
Main Results:
- 157 differentially expressed genes (DEGs) were identified between HCM and normal tissues.
- Immune-related pathways were significantly enriched in HCM pathogenesis.
- Three hub genes (FCN3, MYH6, RASD1) were identified as key players in HCM.
- Knockdown of MYH6 and RASD1 in zebrafish led to cardiac malformations, validating their role in HCM.
Conclusions:
- A novel HCM signature was developed using integrated bioinformatics and machine learning approaches.
- The identified hub genes (MYH6, RASD1) are critical for normal cardiac development and function.
- This signature holds potential for improving early diagnosis and therapeutic strategies for HCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) may lead to cardiac dysfunction and sudden death. This study was designed to develop a HCM signature applying bioinformatics and machine learning methods. Data of HCM and normal tissues were obtained from public databases to screen differentially expressed genes (DEGs) using the R software limma package. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were performed for enrichment analysis of HCM-associated DEGs. Hub genes for HCM were determined using weighted gene co-expression network analysis (WGCNA) together with two machine learning algorithms (SVM-RFE and LASSO). Finally, we introduced a zebrafish model to simulate changes in the hub genes in the HCM and to observe their effects on cardiac disease development. The mRNA expression data from a total of 106 HCM tissues and 39 normal samples were collected and we screened 157 DEGs. Enrichment analysis showed that immune pathways played an important role in the pathogenesis of HCM. Three hub genes (FCN3, MYH6 and RASD1) were identified using WGCNA, SVM-RFE, and LASSO analysis. In a zebrafish model, knockdown of MYH6 and RASD1 resulted in cardiac malformations with reduced ventricular capacity and heart rate, which validated the clinical significance of these genes in the diagnosis of HCM. Based on machine learning algorithms, our study created a signature with potential impact on cardiac function and cardiac quality index for HCM. The current findings had important implications for the early diagnosis and treatment of HCM.
